Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : C3 ( CTHR ) Diamond in the rough? -- Ignore unavailable to you. Want to Upgrade?

To: Sequoia Holdings who wrote (89)	4/18/1998 12:42:00 PM
From: Ron Coby	Respond to of 226

With a 65 million dollar market valuation they better sell a whole bunch of those testers to justify that high of a market cap.

To: Sequoia Holdings who wrote (89)	4/19/1998 6:41:00 PM
From: CrazyTrain	Read Replies (1) \| Respond to of 226

I also learned about CTHR from a friend who owns an upscale jewelry store. He is usually conservative on stocks. He has seen a small sample and was very impressed. He wants to be a distributor. His main concern was that a large diamond dealer might attempt a takeover and sit on the technology. Anyone know how large of a "diamond" they have been successful at producing? Does anyone know if C3 will be making any appearances at any national jeweler events?